Faster routes to adoption and wider uptake across the NHS for life changing healthtech are the key themes in Health Tech Alliance’s (HTA) new Policy Blueprint.
The HTA, chaired by Dame Barbara Hakin, operates with key decision makers and stakeholders across the NHS with an aim of ultimately improving the health of the nation through innovative healthcare technologies.
In the Blueprint’s foreword Dame Barbara Hakin says “NHSE&I estimate that it takes 17 years on average for a new product or device to go from clinical trial stage to mainstream adoption. For innovation to develop across the NHS, this, alongside the level of investment in medical devices, needs to change“.
This document outlines the current, everchanging, adoption challenge alongside patient-centric recommendations for next steps and furthering conversations to approve access to innovative technologies across the UK health system.